Bifunctional Anti-Human Immunodeficiency Virus Type 1 Small Molecules with Two Novel Mechanisms of Action

AUTOR(ES)

Huang, Li

FONTE

American Society for Microbiology

RESUMO

A class of betulinic acid derivatives was synthesized to target two critical steps in the human immunodeficiency virus type 1 (HIV-1) replication cycle, entry and maturation. Each mechanism of HIV-1 inhibition is distinct from clinically available anti-HIV therapeutics. The viral determinants of the antientry and antimaturation activities are the bridging sheet of HIV-1 gp120 and the P24/p2 cleavage site, respectively.

Documentos Relacionados

• New Anti-Human Immunodeficiency Virus Type 1 6-Aminoquinolones: Mechanism of Action
• Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivatives.
• Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities.
• Potential New Anti-Human Immunodeficiency Virus Type 1 Compounds Depress Virus Replication in Cultured Human Macrophages
• Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatment